data_1emz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1emz _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.459 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.71 126.15 32.05 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 117.923 0.862 . . . . 0.0 110.436 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -83.8 68.55 9.97 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.547 0.689 . . . . 0.0 110.064 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.435 ' HA ' ' CE3' ' A' ' 4' ' ' TRP . 7.2 m95 -60.83 -28.25 68.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.302 -0.874 . . . . 0.0 112.519 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.27 -37.28 64.49 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.3 t -104.95 -13.49 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 122.073 -0.663 . . . . 0.0 112.01 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' A' ' 10' ' ' ILE . 74.7 mt -105.26 -2.85 23.55 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.49 -0.756 . . . . 0.0 111.576 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.8 -30.22 69.93 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.909 -1.119 . . . . 0.0 109.02 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.07 -36.62 86.12 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 108.269 -1.933 . . . . 0.0 108.269 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 48.2 mt -59.88 -50.36 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.64 -39.34 90.96 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -63.55 -52.53 60.7 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -60.88 -37.68 83.03 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 118.954 -0.546 . . . . 0.0 110.298 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 t -57.78 -42.68 84.61 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 118.837 0.744 . . . . 0.0 109.125 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -39.6 81.12 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.9 t -63.93 -30.77 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 CA-C-N 118.932 0.787 . . . . 0.0 109.024 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.68 -43.65 84.23 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -70.82 -41.25 71.81 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -61.81 -48.89 78.57 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.348 1.059 . . . . 0.0 111.174 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.17 -62.43 1.48 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.907 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.0 tptm . . . . . 0 N--CA 1.503 2.181 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 179.485 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.459 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.71 126.15 32.05 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 117.923 0.862 . . . . 0.0 110.436 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -83.8 68.55 9.97 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.547 0.689 . . . . 0.0 110.064 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -60.83 -28.25 68.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.302 -0.874 . . . . 0.0 112.519 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.27 -37.28 64.49 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.3 t -104.95 -13.49 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 122.073 -0.663 . . . . 0.0 112.01 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.553 HD22 HD12 ' A' ' 10' ' ' ILE . 74.7 mt -105.26 -2.85 23.55 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.49 -0.756 . . . . 0.0 111.576 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.8 -30.22 69.93 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.909 -1.119 . . . . 0.0 109.02 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.07 -36.62 86.12 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 108.269 -1.933 . . . . 0.0 108.269 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.553 HD12 HD22 ' A' ' 7' ' ' LEU . 48.2 mt -59.88 -50.36 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.64 -39.34 90.96 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 16' ' ' VAL . 1.5 t80 -63.55 -52.53 60.7 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -60.88 -37.68 83.03 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 118.954 -0.546 . . . . 0.0 110.298 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 t -57.78 -42.68 84.61 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 118.837 0.744 . . . . 0.0 109.125 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -39.6 81.12 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 12' ' ' TYR . 41.9 t -63.93 -30.77 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 CA-C-N 118.932 0.787 . . . . 0.0 109.024 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.68 -43.65 84.23 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -70.82 -41.25 71.81 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -61.81 -48.89 78.57 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.348 1.059 . . . . 0.0 111.174 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.17 -62.43 1.48 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.907 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.0 tptm . . . . . 0 N--CA 1.503 2.181 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 179.485 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.459 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.71 126.15 32.05 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 117.923 0.862 . . . . 0.0 110.436 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -83.8 68.55 9.97 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 121.547 0.689 . . . . 0.0 110.064 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -60.83 -28.25 68.67 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.302 -0.874 . . . . 0.0 112.519 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.27 -37.28 64.49 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.3 t -104.95 -13.49 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 122.073 -0.663 . . . . 0.0 112.01 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.553 HD22 HD12 ' A' ' 10' ' ' ILE . 74.7 mt -105.26 -2.85 23.55 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.49 -0.756 . . . . 0.0 111.576 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.8 -30.22 69.93 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.909 -1.119 . . . . 0.0 109.02 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -68.07 -36.62 86.12 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 108.269 -1.933 . . . . 0.0 108.269 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.553 HD12 HD22 ' A' ' 7' ' ' LEU . 48.2 mt -59.88 -50.36 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.64 -39.34 90.96 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 16' ' ' VAL . 1.5 t80 -63.55 -52.53 60.7 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -60.88 -37.68 83.03 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 118.954 -0.546 . . . . 0.0 110.298 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 t -57.78 -42.68 84.61 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 118.837 0.744 . . . . 0.0 109.125 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.52 -39.6 81.12 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 12' ' ' TYR . 41.9 t -63.93 -30.77 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 CA-C-N 118.932 0.787 . . . . 0.0 109.024 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.68 -43.65 84.23 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -70.82 -41.25 71.81 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -61.81 -48.89 78.57 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.348 1.059 . . . . 0.0 111.174 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.17 -62.43 1.48 Allowed 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 119.096 -0.478 . . . . 0.0 110.907 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.0 tptm . . . . . 0 N--CA 1.503 2.181 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 179.485 . . . . . . . . 0 0 . 1 stop_ save_